background image for GxP Lifeline
GxP Lifeline

Showing items tagged as life sciences

  • 3 Reasons to adopt a data-centric quality mindset for life sciences.

    3 Reasons You Should Adopt a Data-Centric Quality Mindset

    To improve quality, life sciences companies need to bring that data together, use automated analytics tools, and use artificial intelligence (AI) to improve performance. There are three main ways we’re preparing to help you do that.

    Full story
  • 2021-bl-steps-to-capa-success_132x132

    7 CAPA Process Steps to Ensure CAPA Success

    Inadequate quality management and poor data can be costly for a life sciences company or similarly regulated industry. However, a strong corrective action/preventive action (CAPA) program paired with a digital CAPA management tool can help differentiate your company from the competition.

    Full story
  • 2021-bl-enterey-change-management_132x132

    Change Management: Enabling Successful Adoption

    In the life sciences digitization is a powerful way to improve efficiency, but the successful adoption of new digital tools requires effective change management.

    Full story
  • 2021-bl-clinical-manufacturing_132x132

    The Secret to Clinical Manufacturing Success: Integrate Quality Early

    Quality takes on a new meaning in the clinical manufacturing sector, where flexibility is critical and production hinges on rapid yet exacting adjustments. Discover how integrating quality early in the manufacturing process gives companies an edge in the fast-paced and highly competitive field.

    Full story
  • 2021-bl-rajesh-talpade-_132x132

    The Future of Responsible AI in Life Sciences

    In life sciences, we are rapidly approaching a time when the use of artificial intelligence and machine learning (AI/ML) will be an industry norm.

    Full story
  • jon-b-blog_01_358x160

    Rapid Acceleration in Technology for Life Sciences Quality and Manufacturing

    We have built technology for life sciences quality and manufacturing for more than 25 years and I have been involved in that effort for 19 years. It wasn’t until 2014 that we realized the why behind what we do and it wasn’t until 2020 that our mission became crystal clear to everyone on our teams.

    Full story
  • 2020-bl-coda-corp-vaccines_132x132

    The Fundamentals of Immunization, Part 2

    The race to develop a safe and effective vaccine against COVID-19 is on, and it has everyone talking. This is the second of a three-part series on the fundamentals of immunization.

    Full story
  • 2020-bl-thumb-align-quality-across-ecosystem_132x132

    How to Align Quality Across an Expanding Ecosystem

    As companies grow more reliant on geographically dispersed contractors, partners, vendors and business units, it gets harder to align quality across all the entities involved. Learn how global companies like Fagron maintain quality consistency across multiple sites and discover why connecting data and processes within a robust digital platform is the surest way to align quality across your entire ecosystem.

    Full story
  • 2019-bl-thumb-summit-irene-brodsky

    Art Intersects With Inspiring Science Applications at the 2019 Masters Summit

    Science and art may seem to have few commonalities, but creative achievements like origami models and musical compositions are closely linked with beneficial scientific applications, according to the keynote addresses at the 2019 Masters Summit. Learn about the insights that origami innovator Dr. Robert Lang and independent filmmaker Irene Taylor Brodsky have discovered in the space where art and technology intersect.

    Full story
  • 2019-bl-thumb-how-the-tga-regulates-drugs-and-devices

    Tips on How the TGA Regulates Drugs, Devices and Combination Products

    Global regulatory requirements are seemingly in a state of constant flux. Thus, it can be confusing for life sciences companies to grasp the exact nature of each region’s regulatory agency policies. This article breaks down some of the regulatory basics and more nuanced portions of Australia’s Therapeutic Goods Administration (TGA).

    Full story
  • 2019-bl-thumb-dia-takeaways

    DIA Global 2019 Recap: 3 Themes Shaping the Future of Life Sciences

    Patient centricity, transformative technologies and the importance of high-quality and clinically meaningful data were the major themes at DIA Global 2019. Learn about the trends having the biggest impact on the evolving life sciences landscape.

    Full story
  • 2018-bl-thumb-regulatory-barriers-for-biotech-medtech-startups-europe

    Regulatory Barriers to Innovation for Startups

    France and Europe are witnessing an explosion of life science innovation from new startups. But what separates the winners from the losers? Learn how to successfully overcome regulatory barriers and get your product to market quicker.

    Full story
[ { "key": "fid#1", "value": ["GxP Lifeline Blog"] } ]